SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001494650-23-000073
Filing Date
2023-07-27
Accepted
2023-07-27 07:27:31
Documents
15
Period of Report
2023-07-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K optn-20230727.htm   iXBRL 8-K 28656
2 EX-99.1 q22023earningsprerelease.htm EX-99.1 10397
6 GRAPHIC image.jpg GRAPHIC 33411
7 GRAPHIC optn-20230727_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-23-000073.txt   239426

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20230727.xsd EX-101.SCH 1904
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20230727_lab.xml EX-101.LAB 24851
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20230727_pre.xml EX-101.PRE 13048
9 EXTRACTED XBRL INSTANCE DOCUMENT optn-20230727_htm.xml XML 2528
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 231115301
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences